Clinical Trials Browser

Phase 1 × Trazodone × Other hematologic neoplasm × Clear all

NCT05136521 2021-11-29

Bioavailability Study of 300 mg Trazodone Hydrochloride (New Polymer) vs. 300 mg Trazodone Hydrochloride (Contramid® Prolonged-release Tablets) Under Fasting Conditions

Phase 1 Completed

Other hematologic neoplasm

Leukemia, Hairy Cell